Snake venom phospholipase A2 (PLA2) that is myotoxic and displays moderate edema-inducing activity in rat paws (PubMed:9028014, PubMed:12623078). Does not show neurotoxic activity (PubMed:15032748, PubMed:9028014). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-glycero-3-phosphocholine + a fatty acid + H(+) Binds 1 Ca(2+) ion. Heparin and wedelolactone inhibit the myotoxic activity (PubMed:9920492). The PLA2 inhibitor, para-bromophenacyl bromide (BPB), inhibits enzymatic and myotoxic activities (PubMed:9028014, PubMed:9920492). When tested as a monomer. Monomer (PubMed:15032748, PubMed:9028014). Binds to calmodulin (PubMed:15032748). Expressed by the venom gland. Does not show neurotoxic activities (PubMed:15032748 and PubMed:9028014). Belongs to the phospholipase A2 family. Group II subfamily. D49 sub-subfamily.